ClinicalTrials.Veeva

Menu

Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED)

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD)

Status and phase

Completed
Phase 1

Conditions

Liver Fibrosis
Hepatitis C Virus

Treatments

Procedure: MRE

Study type

Interventional

Funder types

Industry

Identifiers

NCT00896233
2009_588
0000-132

Details and patient eligibility

About

This study will assess the repeatability of Magnetic Resonance Elastography (MRE) in both healthy volunteers and Hepatitis C Virus (HCV)-infected patients with fibrosis and lay the groundwork for the validation of MRE as an alternative to liver biopsy.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female and at least 18 years of age
  • Generally good health
  • Willing to fast for 8 hours prior to each study visit

Hepatitis C Virus (HCV) Inclusion Criteria:

  • Positive serology for HCV and detectable HCV ribonucleic acid (RNA) in blood within 12 weeks of screening;

For Part I, known fibrosis stage of at least =F2 (METAVIR) or =F3 (Ishak) from biopsy performed within 3 months of screening; For Part 2, known fibrosis stage of F1-F4 (METAVIR) or F1-F6 (Ishak)

  • Never been treated for HCV

Healthy Participant Inclusion Criteria:

  • Documented absence of hepatitis B virus, HCV, acute hepatitis A virus, and human immunodeficiency virus (HIV) within 12 weeks of screening

Exclusion criteria

  • History of stroke, seizures, or neurological disorders
  • Consumption of excessive amounts of alcohol
  • Use of products containing nicotine
  • Unable to hold a breath for 20 seconds
  • Claustrophobia
  • Use of illicit drugs or history of drug or alcohol abuse

HCV-Positive Exclusion Criteria:

  • Evidence or history of chronic hepatitis not caused by HCV
  • HIV

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

MRE
Experimental group
Treatment:
Procedure: MRE

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems